NYSE:NHI
NATIONAL HEALTH INVESTORS INC
A financially resilient healthcare operator delivering steady top-line growth and robust operating cash flows with a diverse portfolio of fixed assets.
Key Metrics
Investment Thesis
Bull Case
Investors should consider NHI for its consistent year-over-year revenue expansion and strong conversion of earnings into operating cash flow which totals $236.6M. The large fixed asset base of $2.47B suggests a mature business model with high barriers to entry and stable service delivery capabilities.
Bear Case
The stock carries elevated risk due to the massive $2.04B other financing cash outflow and significant revolver repayments that may strain liquidity in a tightening credit environment. A substantial retained earnings deficit of $2.75B combined with high interest expenses suggests potential balance sheet fragility if growth decelerates.
About NATIONAL HEALTH INVESTORS INC
NHI provides specialized healthcare services across multiple markets, leveraging a robust asset base of over $2.4 billion to deliver high-margin operational performance. The company has demonstrated consistent revenue growth from $278 million in 2022 to $375.6 million in 2025, supported by strong cash flow generation.
Analysis
Management Discussion
Management successfully expanded revenue by 34% over the last three years while maintaining healthy net profit margins that grew from $65.5M in 2022 to $140.8M in 2025. Despite substantial capital expenditures of $294M and heavy revolver repayments, the firm generated positive operating cash flow of $236.6M, though net cash decreased by $6.9M due to financing outflows.
Industry Overview
The healthcare services industry is characterized by high capital intensity and regulatory complexity, where established players like NHI leverage massive asset bases to secure long-term contracts. Market consolidation continues as firms seek scale to manage rising operational costs and meet increasing demand for specialized patient care.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $278.2M | $319.8M | $335.2M | $375.6M |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $278.2M | $319.8M | $335.2M | $375.6M |
| G&A | $22.8M | $19.3M | $20.7M | $26.9M |
| Stock-Based Comp | $8.6M | $4.6M | $4.2M | $5.6M |
| D&A | — | — | — | $80.9M |
| Depreciation | $70.9M | $70.0M | $71.4M | — |
| Non-Operating Income | $0 | $0 | $0 | $0 |
| Interest Expense | $44.9M | $58.2M | $59.9M | $57.4M |
| Continuing Ops | $65.5M | $134.4M | $136.6M | $140.8M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $65.5M | $134.4M | $136.6M | $140.8M |
| Minority Interest | $-902.0K | $-1.3M | $-1.3M | $-1.4M |
| Net to Common | $66.4M | $135.7M | $138.0M | $142.2M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $19.3M | $22.3M | $24.3M | $19.6M |
| Accounts Receivable | $3.6M | — | — | — |
| PP&E (Net) | — | $2.11B | $2.21B | $2.47B |
| Operating Leases | — | $1.6M | $1.5M | $1.5M |
| Total Assets | $2.51B | $2.49B | $2.61B | $2.80B |
| Total Liabilities | $1.22B | $1.21B | $1.23B | $1.26B |
| Shareholders' Equity | $1.29B | $1.27B | $1.39B | $1.54B |
| Retained Earnings | — | $2.47B | $2.60B | $2.75B |
| Total L&E | $2.51B | $2.49B | $2.61B | $2.80B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $65.5M | $134.4M | $136.6M | $140.8M |
| Non-Cash Adjustments | $124.3M | $41.3M | $64.3M | $88.6M |
| Working Capital Changes | $-4.5M | $8.8M | $6.8M | $7.1M |
| Cash from Operations | $185.3M | $184.4M | $207.8M | $236.6M |
| Capital Expenditures | $11.0M | $49.6M | $157.9M | $294.0M |
| Cash from Investing | $197.9M | $-11.6M | $-192.3M | $-269.1M |
| Debt Repayments | $135.4M | $415.4M | $75.4M | $200.8M |
| Share Buybacks | $152.0M | $0 | $0 | — |
| Dividends Paid | $161.8M | $156.2M | $156.5M | $169.7M |
| Cash from Financing | $-401.3M | $-169.7M | $-13.6M | $25.7M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-18.0M | $3.1M | $1.9M | $-6.9M |
| Beginning Cash | $39.5M | $21.5M | $24.6M | $26.5M |
| Ending Cash | $21.5M | $24.6M | $26.5M | $19.6M |
Frequently Asked Questions
How does NATIONAL HEALTH INVESTORS INC make money?
Primary revenue streams include core healthcare service operations generating $375.6M in gross profit, strategic asset management utilizing a $2.47B net fixed asset base, and affiliate investment activities yielding $3.7M in equity profits.
What are the main risks for NHI?
Significant debt service obligations including $821.2M in revolver repayments and $200.8M in long-term debt maturities create refinancing pressure, high interest expenses of $57.4M could erode margins if rates rise, and a retained earnings deficit of $2.75B indicates historical capital accumulation challenges.
What is NHI's competitive advantage?
The company maintains a substantial net fixed asset portfolio of $2.47B providing significant operational leverage, generates superior operating cash flow of $236.6M relative to its net income, and executes disciplined capital management with over $19M in liquid cash reserves.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.